Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.37 |
| ▸ | CCR8 | P51685 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3294386 | 0.87 | TSHR (0.46) | LMNATSHRTDP1ALDH1A1PDE10A | |
| SCHEMBL28123780 | 0.86 | RAB9A (0.56) | LMNATDP1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL12481395 | 0.82 | F7 (0.39) | LMNATSHRTDP1ALDH1A1PDE10A | |
| SCHEMBL28207101 | 0.80 | NPC1 (0.42) | CYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL28365390 | 0.80 | CYP2A6 (0.56) | ALDH1A1CYP1A2MAPTCYP3A4ABL1 | |
| SCHEMBL17598049 | 0.78 | ERN1 (0.42) | LMNATDP1ALDH1A1CYP1A2MAPT | |
| SCHEMBL4494414 | 0.77 | LMNA (0.38) | LMNATSHRTDP1ALDH1A1PDE10A | |
| SCHEMBL3865531 | 0.77 | GPR35 (0.45) | LMNATSHRTDP1ALDH1A1PDE10A | |
| SCHEMBL873623 | 0.77 | TSHR (0.43) | LMNATSHRTDP1ALDH1A1PDE10A | |
| SCHEMBL18387601 | 0.77 | LMNA (0.38) | LMNATSHRTDP1ALDH1A1PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455690-B2 | Method for producing arylhydroxylamine | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-04 | — | — | US | disclosed |
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2154125-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | Wako Pure Chemical Industries, Ltd. (JP) | 2010-02-17 | — | — | EP | disclosed |
| US-4369318-A | USING A BENZO-OR PYRIDO-CINNOLINES AS BLEACH CATALYST | CIBA-GEIGY LTD. (CH) | 1983-01-18 | — | — | US | disclosed |
| US-4266011-A | FUSED PYRIDAZINE CATALYST | CIBA-GEIGY AG (CH) | 1981-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | PAH, APEH, HPD | LMNA 2497/4885TSHR 2790/4885TDP1 2470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.